Abstract
ASO Visual Abstract: Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Varies in Males Versus Females With Papillary Thyroid Cancer
Annals of surgical oncology
05/26/2025
DOI: 10.1245/s10434-025-17372-z
PMID: 40419712
Abstract
In this study, CD133, a glycoprotein associated with tumor initiation in papillary thyroid carcinoma (PTC), was examined by immunohistochemistry in PTC, and recurrence-free survival (RFS) was compared. Overall, RFS did not differ by CD133 expression, but among the patients with elevated CD133 expression, the males had worse RFS than the females (https:// doi. org/https:// doi. org/ 10. 1245/s10434-025-17256-2)
Details
- Title: Subtitle
- ASO Visual Abstract: Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Varies in Males Versus Females With Papillary Thyroid Cancer
- Creators
- Jeremy Chang - University of IowaEyas M Alzayadneh - University of VirginiaAnand Rajan - University of Iowa, PathologyAndy Tran - University of IowaRonald J Weigel - University of IowaAnna C Beck - University of Wisconsin–Madison
- Resource Type
- Abstract
- Publication Details
- Annals of surgical oncology
- DOI
- 10.1245/s10434-025-17372-z
- PMID
- 40419712
- NLM abbreviation
- Ann Surg Oncol
- ISSN
- 1068-9265
- eISSN
- 1534-4681
- Publisher
- SPRINGER; NEW YORK
- Language
- English
- Electronic publication date
- 05/26/2025
- Academic Unit
- Molecular Physiology and Biophysics; Anatomy and Cell Biology; Pathology; Surgery; Biochemistry and Molecular Biology
- Record Identifier
- 9984825533902771
Metrics
8 Record Views